Name: Paclitaxel For Injectable Suspension 100Mg
SKU: 986
Availability: InStock

Paclitaxel For Injectable Suspension 100Mg

Paclitaxel For Injectable Suspension 100Mg Lyophilised.

Packaging Size	1 Injection in Vial
Strength	100 mg/50 ml
Brand Name	NAB-TAXYRA
Treatment	Used to treat advanced or metastatic (cancer that has spread) breast cancer
Composition	Each ml Contains – Paclitaxel 260 mg

Dosage Form	Liquid
Country of Origin	INDIA

aclitaxel Injections I.P. are chemotherapy medications manufactured according to the quality standards of the Indian Pharmacopoeia (I.P.). They are primarily used to treat advanced or metastatic cancers by stopping the growth and division of cancer cells.

Core Indications

This medication is commonly prescribed for the following conditions:

- Ovarian Cancer: Often as a primary treatment.
- Breast Cancer: For cases that have spread or not responded to other treatments.
- Non-Small Cell Lung Cancer (NSCLC): Frequently used in combination with other drugs.
- Pancreatic Cancer: Specifically used alongside gemcitabine.
- Kaposi’s Sarcoma: A secondary treatment for AIDS-related skin cancer.

Available Strengths & Volume [1]

Paclitaxel I.P. is available in various strengths and volumes to accommodate different treatment protocols.

Administration Protocol

Delivery: Given strictly as an intravenous (IV) infusion by healthcare professionals in a clinical setting.
Schedule: The infusion is administered over a specific duration, typically repeated at regular intervals, such as every three weeks, as determined by a oncologist.
Pre-medication: To prevent severe allergic reactions, patients are usually given steroids and antihistamines before the treatment begins.